Table 3: The contribution of OHD over the five weeks to MetSyn components represented by two models. Model A illustrates the independent contribution of OHD to metabolic parameters and Model B presents the inclusion of both OHD and PTH as independent variables.

STANSPEC
REG Model AΔOHDa valueΔOHDa value

Glucose (mg/dL)−0.06 ± 0.430.88−2.33 ± 1.01*0.04
SI (×10−4 min¹/(μIU/mL))−0.04 ± 0.060.490.66 ± 0.26*0.02
LDL (mg/dL)−1.53 ± 0.60*0.020.99 ± 2.540.70
HDL (mg/dL)−0.33 ± 0.380.39−0.47 ± 0.890.60
Triglycerides (mg/dL)0.67 ± 0.440.144.71 ± 3.460.19
Trunk fat (kg)0.18 ± 0.120.150.35 ± 0.350.34

REG Model BΔOHDa valuePTHa valueΔOHDa valuePTHa value

Glucose (mg/dL)0.68 ± 0.360.070.29 ± 0.07*0.0007−2.31 ± 1.04*0.05−0.14 ± 0.260.60
SI (×10−4 min¹/(μIU/mL))−0.03 ± 0.070.690.00 ± 0.010.730.66 ± 0.22*0.01−0.11 ± 0.05*0.04
LDL (mg/dL)−1.84±0.70*0.02−0.13 ± 0.150.381.10 ± 2.620.680.31 ± 0.550.58
Triglycerides (mg/dL)0.11 ± 0.370.75−0.27 ± 0.07*0.0024.62 ± 3.620.23−0.20 ± 0.850.81

*Indicates significant difference ( ).
avalues represent beta coefficient and standard error.
Abbreviations: insulin sensitivity (SI), low-density lipoprotein (LDL), high-density lipoprotein (HDL), parathyroid hormone (PTH), and change in 25OHD concentration (ΔOHD).